etoposide has been researched along with Histiocytoma, Benign Fibrous in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gabbert, HE; Gerharz, CD; Reinecke, P; Schmitz, M; Steckstor, M | 1 |
Ishihara, T; Matsunaga, W; Yasuno, K | 1 |
Fukumura, M; Furuie, H; Hayashi, Y; Kakuta, Y; Kimura, M; Konishi, T; Morikawa, T; Takeuchi, K; Tashiro, Y | 1 |
Creagan, ET; Kovach, JS; Richardson, RL | 1 |
4 other study(ies) available for etoposide and Histiocytoma, Benign Fibrous
Article | Year |
---|---|
Chemotherapeutic potential of plant alkaloids and multidrug resistance mechanisms in malignant fibrous histiocytoma of the heart.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Separation; Cell Survival; Cells, Cultured; Coloring Agents; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Flow Cytometry; Heart Neoplasms; Histiocytoma, Benign Fibrous; Humans; Inhibitory Concentration 50; Paclitaxel; Phenotype; Plant Extracts; Soft Tissue Neoplasms; Tetrazolium Salts; Thiazoles; Vault Ribonucleoprotein Particles; Vincristine | 2004 |
[A combination chemotherapy of carboplatin and etoposide for malignant fibrous histiocytoma with marked effect on the metastatic lung region].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Etoposide; Female; Histiocytoma, Benign Fibrous; Humans; Lung Neoplasms; Soft Tissue Neoplasms | 1993 |
[Pulmonary malignant fibrous histiocytoma treated with cisplatin plus etoposide followed by surgery].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Female; Histiocytoma, Benign Fibrous; Humans; Lung Neoplasms; Middle Aged | 1995 |
Pilot study of a continuous five-day intravenous infusion of etoposide concomitant with cisplatin in selected patients with advanced cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Histiocytoma, Benign Fibrous; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Stomach Neoplasms; Tongue Neoplasms | 1988 |